Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Time to Focus on Danaher (DHR) for Strong Earnings Growth Potential
03:25pm, Friday, 13'th Aug 2021
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Danaher (DHR).
7 Water Stocks to Buy to Bank on Our Most Precious Resource
12:50pm, Friday, 06'th Aug 2021
As climate change forces a dramatic rethink on how we utilize our resources, these water stocks will certainly gain relevance. The post 7 Water Stocks to Buy to Bank on Our Most Precious Resource appe
Is Danaher a Buy in a Post-Pandemic World?
10:49am, Wednesday, 04'th Aug 2021
Analyzing the investment case for buying stock in the high-flying life sciences and diagnostics company.
3 Stocks With Price and Earnings Estimate Momentum
12:55pm, Friday, 30'th Jul 2021
3 Stocks With Price and Earnings Estimate Momentum
Danaher (DHR) Is Up 2.28% in One Week: What You Should Know
01:43pm, Thursday, 29'th Jul 2021
Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for July 28th
11:25am, Wednesday, 28'th Jul 2021
CROX, ISRG, MIDD, and DHR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2021
5 Top-Ranked Momentum Picks Using Driehaus Strategy
09:55am, Wednesday, 28'th Jul 2021
DHR, CLFD, HCA, FBP, and SNBR qualified as the day's Momentum Picks Using Driehaus Strategy.
Danaher (DHR) is a Top-Ranked Momentum Stock: Should You Buy?
10:44am, Tuesday, 27'th Jul 2021
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions
02:05am, Tuesday, 27'th Jul 2021
AMERSHAM, United Kingdom, July 27, 2021 /PRNewswire/ -- An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capaci
Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund
05:14pm, Monday, 26'th Jul 2021
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the second quarter of the year this week.
Beckman Coulter to Distribute BNP Cardiac Assay to Customers
08:30am, Monday, 26'th Jul 2021
BREA, Calif., July 26, 2021 /PRNewswire/ -- Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain al
Danaher (DHR) Beats on Q2 Earnings, Ups 2021 Core Sales View
11:28am, Thursday, 22'nd Jul 2021
Danaher's (DHR) Q2 results reflect strength in segmental businesses, the impact of pandemic-led tailwinds and improved margins. Projection for core sales growth, including Cytiva, increases for 2021.
Danaher Corporation (DHR) CEO Rainer Blair on Q2 2021 Results - Earnings Call Transcript
11:08am, Thursday, 22'nd Jul 2021
Danaher Corporation (DHR) CEO Rainer Blair on Q2 2021 Results - Earnings Call Transcript
Danaher (DHR) Tops Q2 Earnings and Revenue Estimates
08:26am, Thursday, 22'nd Jul 2021
Danaher (DHR) delivered earnings and revenue surprises of 20.59% and 7.83%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Danaher Posts Higher Profits, Margins On Increased Sales
07:16am, Thursday, 22'nd Jul 2021
Danaher Corporation (NYSE: DHR) logged a higher profit for the second quarter as its sales grew. Adjusted EPS increased 71% Y/Y to $2.46, surpassing the estimate of $2.05.
